BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 22264642)

  • 1. Effects of challenge with a virulent genotype II strain of porcine reproductive and respiratory syndrome virus on piglets vaccinated with an attenuated genotype I strain vaccine.
    Roca M; Gimeno M; Bruguera S; Segalés J; Díaz I; Galindo-Cardiel IJ; Martínez E; Darwich L; Fang Y; Maldonado J; March R; Mateu E
    Vet J; 2012 Jul; 193(1):92-6. PubMed ID: 22264642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
    Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
    Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
    Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
    Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain.
    Martelli P; Cordioli P; Alborali LG; Gozio S; De Angelis E; Ferrari L; Lombardi G; Borghetti P
    Vaccine; 2007 Apr; 25(17):3400-8. PubMed ID: 17276558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective immunity induced by a recombinant pseudorabies virus expressing the GP5 of porcine reproductive and respiratory syndrome virus in piglets.
    Qiu HJ; Tian ZJ; Tong GZ; Zhou YJ; Ni JQ; Luo YZ; Cai XH
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):309-19. PubMed ID: 15963827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural infection with torque teno sus virus 1 (TTSuV1) suppresses the immune response to porcine reproductive and respiratory syndrome virus (PRRSV) vaccination.
    Zhang Z; Wang Y; Fan H; Lu C
    Arch Virol; 2012 May; 157(5):927-33. PubMed ID: 22327391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of live attenuated porcine reproductive and respiratory syndrome virus 2 strains to protect pigs from challenge with a heterologous Vietnamese PRRSV 2 field strain.
    Sattler T; Pikalo J; Wodak E; Revilla-Fernández S; Steinrigl A; Bagó Z; Entenfellner F; Claude JB; Pez F; Francillette M; Schmoll F
    BMC Vet Res; 2018 Apr; 14(1):133. PubMed ID: 29673363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the efficacy of a new modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (Fostera PRRS) against heterologous PRRSV challenge.
    Park C; Seo HW; Han K; Kang I; Chae C
    Vet Microbiol; 2014 Aug; 172(3-4):432-42. PubMed ID: 24970363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similarity of European porcine reproductive and respiratory syndrome virus strains to vaccine strain is not necessarily predictive of the degree of protective immunity conferred.
    Prieto C; Alvarez E; Martínez-Lobo FJ; Simarro I; Castro JM
    Vet J; 2008 Mar; 175(3):356-63. PubMed ID: 17560818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory tract protection upon challenge of pigs vaccinated with attenuated porcine reproductive and respiratory syndrome virus vaccines.
    Labarque G; Van Gucht S; Van Reeth K; Nauwynck H; Pensaert M
    Vet Microbiol; 2003 Sep; 95(3):187-97. PubMed ID: 12935746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic implications of concurrent inoculation with attenuated and virulent strains of porcine reproductive and respiratory syndrome virus.
    Mengeling WL; Lager KM; Wesley RD; Clouser DF; Vorwald AC; Roof MB
    Am J Vet Res; 1999 Jan; 60(1):119-22. PubMed ID: 9918159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy.
    Labarque G; Reeth KV; Nauwynck H; Drexler C; Van Gucht S; Pensaert M
    Vaccine; 2004 Oct; 22(31-32):4183-90. PubMed ID: 15474708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porcine circovirus type 2 infection decreases the efficacy of a modified live porcine reproductive and respiratory syndrome virus vaccine.
    Opriessnig T; McKeown NE; Harmon KL; Meng XJ; Halbur PG
    Clin Vaccine Immunol; 2006 Aug; 13(8):923-9. PubMed ID: 16893993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of modified-live porcine reproductive and respiratory syndrome virus (PRRSv) vaccine on the shedding of wild-type virus from an infected population of growing pigs.
    Linhares DC; Cano JP; Wetzell T; Nerem J; Torremorell M; Dee SA
    Vaccine; 2012 Jan; 30(2):407-13. PubMed ID: 22063389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
    Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
    Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the safety and efficacy of an attenuated live vaccine based on highly pathogenic porcine reproductive and respiratory syndrome virus.
    Yu X; Zhou Z; Cao Z; Wu J; Zhang Z; Xu B; Wang C; Hu D; Deng X; Han W; Gu X; Zhang S; Li X; Wang B; Zhai X; Tian K
    Clin Vaccine Immunol; 2015 May; 22(5):493-502. PubMed ID: 25739919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.
    Evenson D; Gerber PF; Xiao CT; Halbur PG; Wang C; Tian D; Ni YY; Meng XJ; Opriessnig T
    Vaccine; 2016 Nov; 34(46):5546-5553. PubMed ID: 27742217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic responses and reproductive outcomes following exposure to wild-type or attenuated porcine reproductive and respiratory syndrome virus in swine under field conditions.
    Lowe JF; Zuckermann FA; Firkins LD; Schnitzlein WM; Goldberg TL
    J Am Vet Med Assoc; 2006 Apr; 228(7):1082-8. PubMed ID: 16579789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a modified-live porcine reproductive and respiratory syndrome virus vaccine intervention on a population of pigs infected with a heterologous isolate.
    Cano JP; Dee SA; Murtaugh MP; Pijoan C
    Vaccine; 2007 May; 25(22):4382-91. PubMed ID: 17451850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two genetically distant type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccines against Vietnamese highly pathogenic PRRSV.
    Do DT; Park C; Choi K; Jeong J; Nguyen TT; Nguyen KD; Vo DT; Chae C
    Vet Microbiol; 2015 Sep; 179(3-4):233-41. PubMed ID: 26149103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.